Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary.
Sasano T, Mabuchi S, Kuroda H, Kawano M, Matsumoto Y, Takahashi R, Hisamatsu T, Sawada K, Hashimoto K, Isobe A, Testa JR, Kimura T. Sasano T, et al. Among authors: kuroda h. Mol Cancer Res. 2015 Apr;13(4):795-806. doi: 10.1158/1541-7786.MCR-14-0314. Epub 2014 Dec 17. Mol Cancer Res. 2015. PMID: 25519148 Free PMC article.
[Treatment of ovarian clear cell carcinoma].
Mabuchi S, Takahashi R, Sasano T, Kuroda H, Kimura T. Mabuchi S, et al. Among authors: kuroda h. Gan To Kagaku Ryoho. 2015 Feb;42(2):174-8. Gan To Kagaku Ryoho. 2015. PMID: 25834915 Japanese. No abstract available.
The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations.
Sasano T, Mabuchi S, Kozasa K, Kuroda H, Kawano M, Takahashi R, Komura N, Yokoi E, Matsumoto Y, Hashimoto K, Sawada K, Morii E, Kimura T. Sasano T, et al. Among authors: kuroda h. Clin Cancer Res. 2018 Aug 15;24(16):4018-4029. doi: 10.1158/1078-0432.CCR-17-2472. Epub 2018 May 11. Clin Cancer Res. 2018. PMID: 29752277
Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer.
Yokoi E, Mabuchi S, Shimura K, Komura N, Kozasa K, Kuroda H, Takahashi R, Sasano T, Kawano M, Matsumoto Y, Kodama M, Hashimoto K, Sawada K, Kimura T. Yokoi E, et al. Among authors: kuroda h. Invest New Drugs. 2019 Oct;37(5):818-827. doi: 10.1007/s10637-018-0686-6. Epub 2018 Oct 30. Invest New Drugs. 2019. PMID: 30374654
Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature.
Mabuchi S, Matsumoto Y, Kawano M, Minami K, Seo Y, Sasano T, Takahashi R, Kuroda H, Hisamatsu T, Kakigano A, Hayashi M, Sawada K, Hamasaki T, Morii E, Kurachi H, Matsuura N, Kimura T. Mabuchi S, et al. Among authors: kuroda h. J Natl Cancer Inst. 2014 Jun 19;106(7):dju147. doi: 10.1093/jnci/dju147. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24948742
First two cases of primary carcinoma of the vagina successfully treated with concurrent weekly carboplatin plus paclitaxel, external beam radiotherapy and high-dose-rate interstitial brachytherapy: a case report and published work review.
Mabuchi S, Kawano M, Isohashi F, Kuroda H, Sasano T, Kimura T. Mabuchi S, et al. Among authors: kuroda h. J Obstet Gynaecol Res. 2015 Jan;41(1):156-61. doi: 10.1111/jog.12492. Epub 2014 Sep 17. J Obstet Gynaecol Res. 2015. PMID: 25227150 Review.
1,304 results